That the Parliament recognises the publication on 10 March 2026 of the pioneering study, Prospective evaluation of artificial intelligence integration into breast cancer screening in multiple workflow settings: the GEMINI study; further recognises that the study, which was led by the University of Aberdeen, was the UK’s first comprehensive use of Artificial Intelligence (AI) in breast cancer screening to find that AI can increase breast cancer detection by 10.4%; notes that the use of AI was shown to decrease waiting times for patients following screening by 78%, as well as decrease workload for staff by more than 30%; understands that the study was undertaken by the University of Aberdeen in partnership with NHS Grampian and Kheiron Medical Technologies, with funding from the NHS AI in Health and Care Award, and further support from the National Institute for Health and Care Research; commends the authors of the study, including research fellow at the University of Aberdeen, Dr Clarisse de Vries, interdisciplinary institute director of health, nutrition, and wellbeing, Professor Lesley Anderson, and clinical director of breast screenings in the North East of Scotland, Professor Gerald Lip, along with the participants in the study, and hopes that their work can be used to save lives moving forward.